Physician profile
Mark Withrow
NPI 1255338547
$1,925.76
in general payments reported to CMS, 2019-2025
21 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $89.19 · 2021: $274 · 2022: $665 · 2023: $229 · 2024: $289 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $620.90 | 2019-2025 | Liletta, Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $269.77 | 2019-2025 | Veozah, Myrbetriq |
| Aspira Women'S Health INC | $206.42 | 2022 | |
| Myovant Sciences INC. | $113.19 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $105.74 | 2023-2025 | Myfembree |
| Organon LLC | $85.97 | 2023-2025 | Nexplanon |
| Pfizer INC. | $84.56 | 2021-2025 | |
| Exeltis, USA INC. | $70.13 | 2021-2024 | Slynd |
| Mayne Pharma Commercial LLC | $63.81 | 2021-2023 | |
| Avion Pharmaceuticals | $58.31 | 2020-2022 | |
| Boston Scientific Corporation | $56.88 | 2025 | General - Female Sui |
| Sage Therapeutics, LLC | $52.76 | 2024-2025 | Zurzuvae |
| Olympus America INC. | $24.53 | 2019 | |
| Daiichi Sankyo INC. | $22.98 | 2022 | |
| Therapeuticsmd, INC. | $16.06 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $13.79 | 2019 | |
| Allergan, INC. | $13.45 | 2019 | |
| Duchesnay USA Incorporated | $12.58 | 2019 | |
| Merck Sharp & Dohme LLC | $11.63 | 2019 | |
| Lupin INC. | $11.28 | 2019 | |
| Amgen INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Withrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.